The Risk of Peripheral Nerve Tumor Biopsy in Suspected Benign Etiologies

33Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

BACKGROUND: Peripheral nerve sheath tumors (PNSTs) are tumors with unique clinical and imaging features that present to a variety of physicians. These lesions are often referred for biopsy, which can put nerve fascicles at risk. Preoperative biopsy may cause distortion of normal anatomic planes, making definitive resection difficult. OBJECTIVE: To evaluate the neurological risks of preoperative biopsy in benign PNSTs. METHODS: Surgical cases collected retrospectively using a prospectively established database of PNSTs treated by a single surgeon between 1997 and 2019. Patients were dichotomized depending on preoperative biopsy. The effects of biopsy were assessed via history and physical examination both pre- and postdefinitive resection. RESULTS: A total of 151 cases were included. Only 23.2% (35) of patients underwent preoperative biopsy, but 42.9% of these experienced new or worsening neurological examination immediately following biopsy. After definitive resection, the rate of neurological deficit was significantly different between the 2 groups with 60% of biopsy patients and 19% of those patients not biopsied experiencing decline in examination (F = 25.72, P

Cite

CITATION STYLE

APA

Perez-Roman, R. J., Shelby Burks, S., Debs, L., Cajigas, I., & Levi, A. D. (2020). The Risk of Peripheral Nerve Tumor Biopsy in Suspected Benign Etiologies. Clinical Neurosurgery, 86(3), E326–E332. https://doi.org/10.1093/neuros/nyz549

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free